Zimmer Biomet Holdings 将来の成長

NYSE:ZBH - アナリストの将来予測と過去の財務データ ( )USD Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
12/31/2026	8,387	1,266	1,744	2,175	23
12/31/2025	8,023	1,120	1,479	2,043	28
12/31/2024	7,669	1,004	987	1,442	26
9/30/2024	7,596	1,084	992	1,582	N/A
6/30/2024	7,525	997	821	1,523	N/A
3/31/2024	7,452	964	807	1,502	N/A
12/31/2023	7,394	1,024	892	1,582	N/A
9/30/2023	7,279	474	548	1,237	N/A
6/30/2023	7,196	506	724	1,351	N/A
3/31/2023	7,108	450	858	1,355	N/A
12/31/2022	6,940	290	839	1,285	N/A
9/30/2022	6,892	366	970	1,406	N/A
6/30/2022	6,908	334	957	1,389	N/A
3/31/2022	6,889	325	1,078	1,490	N/A
12/31/2021	6,827	445	1,074	1,499	N/A
9/30/2021	7,135	834	1,164	1,559	N/A
6/30/2021	7,379	914	1,132	1,507	N/A
3/31/2021	6,842	563	618	1,000	N/A
12/31/2020	6,128	-11	834	1,205	N/A
9/30/2020	7,065	-152	762	1,203	N/A
6/30/2020	7,028	37	899	1,399	N/A
3/31/2020	7,791	377	1,008	1,753	N/A
12/31/2019	7,982	1,132	865	1,586	N/A
9/30/2019	7,928	-90	830	1,542	N/A
6/30/2019	7,872	-359	750	1,448	N/A
3/31/2019	7,891	-308	1,087	1,541	N/A
12/31/2018	7,933	-379	1,308	1,747	N/A
9/30/2018	7,930	1,753	1,324	1,771	N/A
6/30/2018	7,907	1,690	N/A	1,750	N/A
3/31/2018	7,849	1,689	N/A	1,797	N/A
12/31/2017	7,803	1,814	N/A	1,582	N/A
9/30/2017	7,748	652	N/A	1,807	N/A
6/30/2017	7,768	712	N/A	1,696	N/A
3/31/2017	7,752	497	N/A	1,635	N/A
12/31/2016	7,668	306	N/A	1,632	N/A
9/30/2016	7,604	363	N/A	1,468	N/A
6/30/2016	7,534	227	N/A	1,214	N/A
3/31/2016	6,767	84	N/A	1,031	N/A
12/31/2015	5,998	147	N/A	850	N/A
9/30/2015	5,287	174	N/A	742	N/A
6/30/2015	4,631	325	N/A	899	N/A
3/31/2015	4,646	670	N/A	956	N/A
12/31/2014	4,673	720	N/A	1,061	N/A
9/30/2014	4,691	802	N/A	999	N/A
6/30/2014	4,659	784	N/A	1,036	N/A
3/31/2014	4,646	764	N/A	971	N/A
12/31/2013	4,623	780	N/A	963	N/A

アナリストによる今後の成長予測

収入対貯蓄率: ZBHの予測収益成長率 (年間8.1% ) は貯蓄率 ( 2.6% ) を上回っています。

収益対市場: ZBHの収益 ( 8.1% ) US市場 ( 15.4% ) よりも低い成長が予測されています。

高成長収益: ZBHの収益は増加すると予測されていますが、大幅には増加しません。

収益対市場: ZBHの収益 ( 4.3% ) US市場 ( 9% ) よりも低い成長が予測されています。

高い収益成長: ZBHの収益 ( 4.3% ) 20%よりも低い成長が予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: ZBHの自己資本利益率は、3年後には低くなると予測されています ( 14.6 %)。

Zimmer Biomet Holdings 将来の成長

Future 基準チェック /16

主要情報

今後の成長に関する最新情報

Results: Zimmer Biomet Holdings, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates

Zimmer Biomet Holdings, Inc. Updates Financial Guidance for the Ending December 31, 2024

Zimmer Biomet Holdings, Inc. Revises Earnings Guidance for the Year Ending December 31, 2024

Zimmer Biomet Holdings, Inc. Reiterates Financial Guidance for Current Full-Year 2024

Zimmer Biomet Holdings, Inc. Provides Earnings Guidance for the Full Year 2024

Zimmer Biomet Holdings, Inc. Updates Revenue Guidance for the Year Ending December 31, 2023

Recent updates

Zimmer Biomet Holdings, Inc. Appoints Arnold Schwarzenegger as Chief Movement Officer

Shareholders Can Be Confident That Zimmer Biomet Holdings' (NYSE:ZBH) Earnings Are High Quality

Results: Zimmer Biomet Holdings, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates

Zimmer Biomet Holdings, Inc. Updates Financial Guidance for the Ending December 31, 2024

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

Zimmer Biomet to Debut New Z1™ Femoral Hip System and Clinical Data on G7® Acetabular System at 2024 AAHKS Annual Meeting

Zimmer Biomet Holdings, Inc. to Report Q3, 2024 Results on Oct 30, 2024

Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) Share Price Not Quite Adding Up

Zimmer Biomet: The Undervalued Titan Of Joint Replacements

Upcoming dividend of US$0.24 per share

Zimmer Biomet Stock: Don't Jump In At The 52-Week Low

We Like These Underlying Return On Capital Trends At Zimmer Biomet Holdings (NYSE:ZBH)

Zimmer Biomet Holdings, Inc. Appoints David Demartino as Senior Vice President, Investor Relations

Zimmer Biomet Holdings (NYSE:ZBH) Is Due To Pay A Dividend Of $0.24

Second quarter dividend of US$0.24 announced

Zimmer Biomet Announces Quarterly Dividend for Third Quarter of 2024, Payable on or About October 31, 2024

Zimmer Biomet Holdings (NYSE:ZBH) Seems To Use Debt Quite Sensibly

Second quarter 2024 earnings: EPS misses analyst expectations

Zimmer Biomet Holdings, Inc. Revises Earnings Guidance for the Year Ending December 31, 2024

Are Investors Undervaluing Zimmer Biomet Holdings, Inc. (NYSE:ZBH) By 45%?

Zimmer Biomet Holdings, Inc. to Report Q2, 2024 Results on Aug 07, 2024

Investors Interested In Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) Earnings

Zimmer Biomet: Brighter Prospects In H2 2024

Zimmer Biomet Holdings, Inc. Appoints Devdatt Kurdikar to its Board of Directors

Zimmer Biomet Holdings (NYSE:ZBH) Has Affirmed Its Dividend Of $0.24

Upcoming dividend of US$0.24 per share

President of Asia Pacific recently sold US$1.5m worth of stock

When Should You Buy Zimmer Biomet Holdings, Inc. (NYSE:ZBH)?

President of Asia Pacific notifies of intention to sell stock

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) announces an Equity Buyback for $2,000 million worth of its shares.

Now 22% undervalued after recent price drop

Zimmer Biomet Holdings' (NYSE:ZBH) Dividend Will Be $0.24

Zimmer Biomet Holdings: Moving Along

First quarter dividend of US$0.24 announced

Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2024, Payable on or About July 31, 2024

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Zimmer Biomet Holdings, Inc. Reiterates Financial Guidance for Current Full-Year 2024

The Return Trends At Zimmer Biomet Holdings (NYSE:ZBH) Look Promising

Zimmer Biomet Holdings, Inc. to Report Q1, 2024 Results on May 02, 2024

Zimmer Biomet Holdings, Inc., Annual General Meeting, May 10, 2024

Is Zimmer Biomet Holdings (NYSE:ZBH) Using Too Much Debt?

Upcoming dividend of US$0.24 per share

Zimmer Biomet Holdings (NYSE:ZBH) Will Pay A Dividend Of $0.24

Senior VP notifies of intention to sell stock

Fourth quarter dividend of US$0.24 announced

Zimmer Biomet Holdings, Inc. Announces U.S. Food and Drug Administration (FDA) 510(K) Clearance of the Rosa® Shoulder System for Robotic-Assisted Shoulder Replacement Surgery

Zimmer Biomet Holdings, Inc. Announces Quarterly Cash Dividend for the First Quarter of 2024, Payable on or About April 30, 2024

Zimmer Biomet Holdings' (NYSE:ZBH) Strong Earnings Are Of Good Quality

Zimmer Biomet Holdings, Inc. Showcases Latest Innovations Across Comprehensive Portfolio at AAOS 2024 Annual Meeting

What Does Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) Share Price Indicate?

Full year 2023 earnings: EPS exceeds analyst expectations

Zimmer Biomet Holdings, Inc. Provides Earnings Guidance for the Full Year 2024

Zimmer Biomet: Weight Loss Drug Concerns Are Overblown

A Look At The Fair Value Of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

Zimmer Biomet: Growth Acceleration Is Likely Driven By ROSA; Initiate With 'Buy'

Zimmer Biomet Holdings, Inc. to Report Q4, 2023 Results on Feb 08, 2024

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Not Flying Under The Radar

Zimmer Biomet Holdings, Inc. Announces Appointment of Louis A. Shapiro to Board of Directors

The Returns At Zimmer Biomet Holdings (NYSE:ZBH) Aren't Growing

Upcoming dividend of US$0.24 per share at 0.8% yield

Zimmer Biomet Holdings: Visible Growth Drivers And Strong Execution

Here's Why Zimmer Biomet Holdings (NYSE:ZBH) Can Manage Its Debt Responsibly

Zimmer Biomet Holdings, Inc. Approves Cash Dividend for the Fourth Quarter of 2023, Payable on or About January 31, 2024

Zimmer Biomet: Still Many Questions After A Solid Year So Far

Third quarter 2023 earnings: EPS misses analyst expectations

Zimmer Biomet Holdings, Inc. Updates Revenue Guidance for the Year Ending December 31, 2023

Zimmer Biomet Holdings, Inc. Updates Revenue Guidance for the Year Ending December 31, 2023

When Should You Buy Zimmer Biomet Holdings, Inc. (NYSE:ZBH)?

Zimmer Biomet Holdings, Inc. to Report Q3, 2023 Results on Nov 07, 2023